Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Ruzickova Kirchnerova, M. Terl, H. Mirka, J. Baxa, V. Hrabe (Pilsen, Czech Republic). Complex treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthmatic patient including anti-IgE therapy – A case report. Eur Respir J 2012; 40: Suppl. 56, 1957

Member's Comments

No comment yet.

Related content which might interest you: Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Retrospective study on the combined use of voriconazole and prednisolone in the treatment of acute allergic bronchopulmonary aspergillosis (ABPA). Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 IgE expression in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Asthma Year: 2013 Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017 Vitamin D deficiency in asthma patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Omalizumab in patients with allergic bronchopulmonary aspergillosis (ABPA): a multicenter case series study in Spain Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Omalizumab and voriconazole in allergic broncopulmonary aspergillosis (A case series) Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Allergic bronchopulmonary aspergillosis (ABPA) prevalence in adult cystic fibrosis (CF) patients. Usefulness of recombinant Aspergillus fumigatus IgE (rAsp f) in diagnosis and monitoring treatment Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012 Effect of itraconazole therapy on disease course in 3 cases of allergic bronchopulmonary mycosis presented as refractory asthma Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond Year: 2008 Treating allergic bronchopulmonary aspergillosis: the way forward Source: Eur Respir J 2016; 47: 385-387 Year: 2016 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013 Itraconazole and allergic bronchopulmonary aspergillosis: long-term follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 432s Year: 2001 Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Elevated CEA levels in sera in patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011